DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde


von Minckwitz G, Timms K, Untch M. et al.
Homologous repair deficiency (HRD) as measure to predict the effect of carboplatin on survival in the neoadjuvant phase II trial GeparSixto in triple-negative early breast cancer.

Cancer Res 2017;
77: P1-09-02

Download Bibliographical Data

Search in: